In an effort to help end the pandemic, an international coalition of medical experts is holding worldwide events Saturday to raise awareness about the effectiveness of ivermectin as a treatment for COVID-19.
Organizers of the World Ivermectin Day say doctors and supporters of the inexpensive FDA-approved drug will host free online and public events in over a dozen countries.
Two nonprofits—Front Line COVID-19 Critical Care (FLCCC) Alliance and the British Ivermectin Recommendation Development (BIRD) group—who have been campaigning for the off-label use of ivermectin to prevent and treat COVID-19 say the event’s focus is to let more people know that the antiparasitic drug can treat COVID-19, possibly end the pandemic, and help eliminate fear of the CCP (Chinese Communist Party) virus.
“We have an incredibly positive and uplifting message to share: ivermectin treats and prevents COVID and it is the key to unlocking the never-ending cycle of pandemic peaks and personal restrictions and will help restart economies,” Dr. Tess Lawrie, cofounder of the BIRD group said in a press release.
Lawrie is also a co-author of a peer-reviewed meta-analysis study published in the American Journal of Therapeutics that found ivermectin to be effective against COVID-19, the disease caused by the CCP virus. Lawrie and her team concluded with a moderate level of confidence that ivermectin reduced the risk of death by an average of 62 percent, at a 95 percent confidence interval of 0.19-0.73, especially when prescribed early.
FLCCC Alliance also conducted their own review of 18 randomized controlled trials on COVID-19 treatment with ivermectin. They found “large, statistically significant reductions in mortality, time to clinical recovery, and time to viral clearance.” The authors also said that studies on the prevention of COVID-19 reported significantly reduced risks of the disease with regular use of the drug.
Members of the FLCCC Alliance have developed various protocols for the prevention and early treatment of COVID-19, instead of having patients wait until they develop a severe illness to receive treatment at the hospital. These treatment protocols including one for the management of long COVID are being used globally.
The current standard protocol for COVID-19 positive patients is to isolate at home, avoid dehydration, rest, and take over-the-counter medications for fever, headache, cough, and body pain.
According to updated guidance from the National Institutes of Health (NIH), patients with mild to moderate COVID-19 and who are at high risk of disease progression, are recommended to take a monoclonal antibody if hospitalization or supplemental oxygen is not required.
Despite evidence showing ivermectin may treat all stages of COVID-19 and reduce death and hospitalization as a result of its anti-viral and anti-inflammatory properties, the FDA has not approved its use, saying that the drug isn’t an anti-viral. The federal regulator issued a warning that people should not take ivermectin intended for horses as the larger doses may be harmful to humans.
The NIH has not changed its neutral stance on the use of ivermectin to treat COVID-19, while the World Health Organization (WHO) does not recommend the use of the drug except in a clinical study. Both organizations cite insufficient data for not making a recommendation.
Online discussions of ivermectin have faced an unprecedented level of suppression with doctors claiming that their videos are being taken down or their LinkedIn accounts closed.
Lawrie said she has experienced censorship with her work on ivermectin, claiming that her videos about the drug have been removed and posts censored on social media.
“I have experienced a lot of censorship ever since I started doing work on ivermectin (never before),” Lawrie told The Epoch Times via email. “I have had my post of my published peer-reviewed scientific manuscript removed from LinkedIn.”
She also said that many people have informed her that their accounts would be restricted or censored “if they post the work my company has produced on ivermectin or interviews that I have done.”
LinkedIn did not reply to a request for comment.
Dr. Mobeen Syed, chief executive officer of Drbeen Corp, an online medical education, said YouTube took down three of his videos on ivermectin within 24 hours.
“[Third] book burnt in 24 hours. @Youtube @TeamYouTube continue to burn books,” Syed said on Twitter on July 11. “This video was important to keep people safe who are using ivermectin regardless of what YouTube thinks.”
YouTube did not reply to The Epoch Times inquiry on clarification of which terms or conditions Syed’s videos had violated.
Ivermectin is not the only topic being suppressed or blocked by Big Tech firms. Social media posts about the lab leak theory that the CCP virus escaped from a laboratory in Wuhan, China, and information that goes against the narrative about the safety and efficacy of the COVID-19 vaccine has also been censored.
White House Press Secretary Jen Psaki suggested at a White House briefing that people should be banned from all social media platforms if they post misinformation online about COVID-19 vaccines, alleging that this type of information was “leading to people not taking the vaccine.” Psaki’s suggestion has drawn widespread condemnation.
Regardless of the suppression of ivermectin around the world, people have found unique ways to get the information out. Social media posts of lawn signs have appeared in Manitoba, Canada with a simple message that reads, “Ivermectin treats COVID-19” along with the FLCCC website listed.
— Mr. & Mrs. Fred Fredderson (@FredFredderson1) July 20, 2021
Members of the FLCCC Alliance said in a reply to an email that they would continue their mission in getting ivermectin approved for COVID-19 despite the censorship.
“Thank you for your email. Abandoning our mission is not [an] option. Yes, it has been hell. But as Winston Churchill once said, ‘If you’re going through hell, keep going.’ So if we need to leave you here, we understand. But we’ll march on. Your life matters that much,” the nonprofit said earlier this month.